Emily Pimblett, CHIEF ACCOUNTING OFFICER at Eliem Therapeutics, Inc. (ELYM), sold 1,245 shares at $7.21 ($9K) on 2024-06-20, disclosed to the SEC on 2024-06-21.
Open-market sale of $9k ELYM by CHIEF ACCOUNTING OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLYM | SELL | 2024-12-20 | $2K | — | Filing → |
| ELYM | SELL | 2024-09-20 | $10K | — | Filing → |